Global Remdesivir market is expected to reach USD9913.38 million by 2026. Remdesivir, a drug originally developed by Gilead Sciences, Inc. for the treatment of Ebola, is an antiviral medication belonging to the drug class of protease inhibitors. Remdesivir is a nucleotide analog particularly of adenosine, which shuts down the viral replication process by inhibiting the activity of an important viral enzyme RNA-dependent RNA polymerase. The drug basically causes mutation in viral genome and blocks polymerase enzymes function, which brings about premature termination of viral replication.

The global remdesivir market is driven by the increasing prevalence of COVID-19 pandemic across different parts of the globe. Remdesivir has been found to be effective in treating novel coronavirus disease patients across different parts of the globe. The Chinese have also been using the drug on compassionate use basis. Additionally, the drug was also used on the very first COVID-19 patient in the US, a young man in Snohomish country in Washington. He was given the drug when his condition worsened, and signs of improvement were observed on the very next day in his condition after the drug administration. A Californian patient, who the doctors thought, will not survive, also recovered after getting remdesivir. Promising results were also observed in Japan on 14 patients. After such cases and evidences, the US Food and Drug Administration granted approval to Remdesivir in Oct 2020 and the world is hoping that it will emerge out as a successful coronavirus treatment in coming years as well. 

The global remdesivir market is segmented based on dosage form, route of administration, patient age, distribution channel, application, company, and region. Based on dosage form, the market can be categorized into frozen solution, and lyophilized solution. The lyophilized segment is expected to hold significant market share on account of their longer shelf life. Additionally, they are cost effective, safe and an effective way to deliver medication.

Regionally, Asia Pacific is expected to witness significant growth during the forecast period in the overall remdesivir market owing to increasing number of COVID-19 patients and huge number of hospitalization cases along with increasing demand for remdesivir for the treatment of COVID-19.  

Major players operating in the global remdesivir market include Gilead Sciences, Inc., Cipla Ltd., Hetero Labs Ltd., Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.), Dr Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Jubilant Pharmova Ltd., Eva Pharma, Ferozsons Laboratories and others.

Years considered for this report:

Base Year: 2020

Estimated Year: 2021E

Forecast Period: 2022F–2026F

Objective of the Study:

  • To analyze and estimate the market size of global remdesivir market in 2020.
  • To estimate and forecast the market size of global remdesivir market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global remdesivir market based on dosage form, route of administration, patient age, application, distribution channel, company, and regional distribution.
  • To identify dominant region or segment in the global remdesivir market.
  • To identify drivers and challenges for global remdesivir market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global remdesivir market.
  • To conduct pricing analysis for global remdesivir market.
  • To identify and analyze the profile of leading players operating in global remdesivir market.
  • To identify key sustainable strategies adopted by market players in global remdesivir market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global remdesivir market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Remdesivir manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to remdesivir
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global remdesivir market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Remdesivir Market, By Dosage Form:
    • Lyophilized Solution
    • Frozen Solution
  • Global Remdesivir Market, By Route of Administration:
    • Intravenous
    • Inhalation
  • Global Remdesivir Market, By Patient Age:
    • Geriatric
    • Adult
    • Pediatric
  • Global Remdesivir Market, By Application:
    • SARS-CoV-2 (COVID-19)
    • MERS-CoV
    • Ebola
    • SARS-CoV
  • Global Remdesivir Market, By Distribution Channel:
    • Hospitals
    • Clinics
    • Drug Stores and Pharmacies
  • Global Remdesivir Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Asia-Pacific
      • India
      • Japan
      • China
      • South Korea
      • Australia
    • Europe
      • France
      • United Kingdom
      • Italy
      • Germany
      • Spain
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • Iran
      • South Africa
      • UAE
      • Saudi Arabia
      • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global remdesivir market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Remdesivir Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Brand Awareness (Aided/Unaided)

5.2.  Product Awareness

5.3.  Customer Satisfaction Analysis

5.4.  Unmet Needs/Challenges

6.    Global Remdesivir Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Dosage Form (Lyophilized Solution, Frozen Solution)

6.2.2.     By Route of Administration (Intravenous, Inhalation)

6.2.3.     By Patient Age (Geriatric, Adult, Pediatric)

6.2.4.     By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV)

6.2.5.     By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies)

6.2.6.     By Company (2020)

6.2.7.     By Region

6.3.  Product Market Map

7.    North America Remdesivir Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Dosage Form

7.2.2.     By Route of Administration

7.2.3.     By Patient Age

7.2.4.     By Application

7.2.5.     By Distribution Channel

7.2.6.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Remdesivir Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Dosage Form

7.3.1.2.2.             By Route of Administration

7.3.1.2.3.             By Patient Age

7.3.1.2.4.             By Application

7.3.1.2.5.             By Distribution Channel

7.3.2.     Mexico Remdesivir Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Dosage Form

7.3.2.2.2.             By Route of Administration

7.3.2.2.3.             By Patient Age

7.3.2.2.4.             By Application

7.3.2.2.5.             By Distribution Channel

7.3.3.     Canada Remdesivir Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Dosage Form

7.3.3.2.2.             By Route of Administration

7.3.3.2.3.             By Patient Age

7.3.3.2.4.             By Application

7.3.3.2.5.             By Distribution Channel

8.    Asia-Pacific Remdesivir Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Dosage Form

8.2.2.     By Route of Administration

8.2.3.     By Patient Age

8.2.4.     By Application

8.2.5.     By Distribution Channel

8.2.6.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     India Remdesivir Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Dosage Form

8.3.1.2.2.             By Route of Administration

8.3.1.2.3.             By Patient Age

8.3.1.2.4.             By Application

8.3.1.2.5.             By Distribution Channel

8.3.2.     Japan Remdesivir Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Dosage Form

8.3.2.2.2.             By Route of Administration

8.3.2.2.3.             By Patient Age

8.3.2.2.4.             By Application

8.3.2.2.5.             By Distribution Channel

8.3.3.     China Remdesivir Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Dosage Form

8.3.3.2.2.             By Route of Administration

8.3.3.2.3.             By Patient Age

8.3.3.2.4.             By Application

8.3.3.2.5.             By Distribution Channel

8.3.4.     South Korea Remdesivir Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Dosage Form

8.3.4.2.2.             By Route of Administration

8.3.4.2.3.             By Patient Age

8.3.4.2.4.             By Application

8.3.4.2.5.             By Distribution Channel

8.3.5.     Australia Remdesivir Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Dosage Form

8.3.5.2.2.             By Route of Administration

8.3.5.2.3.             By Patient Age

8.3.5.2.4.             By Application

8.3.5.2.5.             By Distribution Channel

9.    Europe Remdesivir Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Dosage Form

9.2.2.     By Route of Administration

9.2.3.     By Patient Age

9.2.4.     By Application

9.2.5.     By Distribution Channel

9.2.6.     By Country

9.3.  Europe: Country Analysis

9.3.1.     France Remdesivir Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Dosage Form

9.3.1.2.2.             By Route of Administration

9.3.1.2.3.             By Patient Age

9.3.1.2.4.             By Application

9.3.1.2.5.             By Distribution Channel

9.3.2.     United Kingdom Remdesivir Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Dosage Form

9.3.2.2.2.             By Route of Administration

9.3.2.2.3.             By Patient Age

9.3.2.2.4.             By Application

9.3.2.2.5.             By Distribution Channel

9.3.3.     Italy Remdesivir Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Dosage Form

9.3.3.2.2.             By Route of Administration

9.3.3.2.3.             By Patient Age

9.3.3.2.4.             By Application

9.3.3.2.5.             By Distribution Channel

9.3.4.     Germany Remdesivir Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Dosage Form

9.3.4.2.2.             By Route of Administration

9.3.4.2.3.             By Patient Age

9.3.4.2.4.             By Application

9.3.4.2.5.             By Distribution Channel

9.3.5.     Spain Remdesivir Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Dosage Form

9.3.5.2.2.             By Route of Administration

9.3.5.2.3.             By Patient Age

9.3.5.2.4.             By Application

9.3.5.2.5.             By Distribution Channel

10.  South America Remdesivir Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Dosage Form

10.2.2.  By Route of Administration

10.2.3.  By Patient Age

10.2.4.  By Application

10.2.5.  By Distribution Channel

10.2.6.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Remdesivir Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Dosage Form

10.3.1.2.2.           By Route of Administration

10.3.1.2.3.           By Patient Age

10.3.1.2.4.           By Application

10.3.1.2.5.           By Distribution Channel

10.3.2.  Argentina Remdesivir Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Dosage Form

10.3.2.2.2.           By Route of Administration

10.3.2.2.3.           By Patient Age

10.3.2.2.4.           By Application

10.3.2.2.5.           By Distribution Channel

10.3.3.  Colombia Remdesivir Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Dosage Form

10.3.3.2.2.           By Route of Administration

10.3.3.2.3.           By Patient Age

10.3.3.2.4.           By Application

10.3.3.2.5.           By Distribution Channel

11.  Middle East and Africa Remdesivir Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Dosage Form

11.2.2.  By Route of Administration

11.2.3.  By Patient Age

11.2.4.  By Application

11.2.5.  By Distribution Channel

11.2.6.  By Country

11.3.              MEA: Country Analysis

11.3.1.  Iran Remdesivir Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Dosage Form

11.3.1.2.2.           By Route of Administration

11.3.1.2.3.           By Patient Age

11.3.1.2.4.           By Application

11.3.1.2.5.           By Distribution Channel

11.3.2.  South Africa Remdesivir Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Dosage Form

11.3.2.2.2.           By Route of Administration

11.3.2.2.3.           By Patient Age

11.3.2.2.4.           By Application

11.3.2.2.5.           By Distribution Channel

11.3.3.  UAE Remdesivir Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Dosage Form

11.3.3.2.2.           By Route of Administration

11.3.3.2.3.           By Patient Age

11.3.3.2.4.           By Application

11.3.3.2.5.           By Distribution Channel

11.3.4.  Saudi Arabia Remdesivir Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Dosage Form

11.3.4.2.2.           By Route of Administration

11.3.4.2.3.           By Patient Age

11.3.4.2.4.           By Application

11.3.4.2.5.           By Distribution Channel

11.3.5.  Kuwait Remdesivir Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Dosage Form

11.3.5.2.2.           By Route of Administration

11.3.5.2.3.           By Patient Age

11.3.5.2.4.           By Application

11.3.5.2.5.           By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Pricing Analysis

15.  Patent Analysis

16.  Competitive Landscape

16.1.              Gilead Sciences, Inc.

16.2.              Cipla Ltd.

16.3.              Hetero Labs Ltd.

16.4.              Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.)

16.5.              Dr Reddy's Laboratories Ltd.

16.6.              Sun Pharmaceutical Industries Ltd.

16.7.              Cadila Healthcare Ltd.

16.8.              Jubilant Pharmova Ltd.

16.9.              Eva Pharma Ltd.

16.10.            Ferozsons Laboratories

17.  Strategic Recommendations

18.   About Us & Disclaimer

  • Figure 1:               Global Remdesivir Market Size, By Value (USD Million), 2020-2026F

    Figure 2:               Global Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

    Figure 3:               Global Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

    Figure 4:               Global Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

    Figure 5:               Global Remdesivir Market Share, By Application, By Value, 2020-2026F

    Figure 6:               Global Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

    Figure 7:               Global Remdesivir Market Share, By Company, By Value, 2020

    Figure 8:               Global Remdesivir Market Share, By Region, By Value, 2020-2026F

    Figure 9:               Global Remdesivir Product Market Map, By Value, 2020-2026F

    Figure 10:            North America Remdesivir Market Size, By Value (USD Million), 2020-2026F

    Figure 11:            North America Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

    Figure 12:            North America Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

    Figure 13:            North America Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

    Figure 14:            North America Remdesivir Market Share, By Application, By Value, 2020-2026F

    Figure 15:            North America Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

    Figure 16:            North America Remdesivir Market Share, By Country, By Value, 2020-2026F

    Figure 17:            United States Remdesivir Market Size, By Value (USD Million), 2020-2026F

    Figure 18:            United States Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

    Figure 19:            United States Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

    Figure 20:            United States Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

    Figure 21:            United States Remdesivir Market Share, By Application, By Value, 2020-2026F

    Figure 22:            United States Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

    Figure 23:            Mexico Remdesivir Market Size, By Value (USD Million), 2020-2026F

    Figure 24:            Mexico Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

    Figure 25:            Mexico Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

    Figure 26:            Mexico Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

    Figure 27:            Mexico Remdesivir Market Share, By Application, By Value, 2020-2026F

    Figure 28:            Mexico Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

    Figure 29:            Canada Remdesivir Market Size, By Value (USD Million), 2020-2026F

    Figure 30:            Canada Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

    Figure 31:            Canada Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

    Figure 32:            Canada Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

    Figure 33:            Canada Remdesivir Market Share, By Application, By Value, 2020-2026F

    Figure 34:            Canada Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

    Figure 35:            Asia-Pacific Remdesivir Market Size, By Value (USD Million), 2020-2026F

    Figure 36:            Asia-Pacific Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

    Figure 37:            Asia-Pacific Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

    Figure 38:            Asia-Pacific Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

    Figure 39:            Asia-Pacific Remdesivir Market Share, By Application, By Value, 2020-2026F

    Figure 40:            Asia-Pacific Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

    Figure 41:            Asia-Pacific Remdesivir Market Share, By Country, By Value, 2020-2026F

    Figure 42:            India Remdesivir Market Size, By Value (USD Million), 2020-2026F

    Figure 43:            India Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

    Figure 44:            India Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

    Figure 45:            India Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

    Figure 46:            India Remdesivir Market Share, By Application, By Value, 2020-2026F

    Figure 47:            India Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

    Figure 48:            Japan Remdesivir Market Size, By Value (USD Million), 2020-2026F

    Figure 49:            Japan Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

    Figure 50:            Japan Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

    Figure 51:            Japan Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

    Figure 52:            Japan Remdesivir Market Share, By Application, By Value, 2020-2026F

    Figure 53:            Japan Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

    Figure 54:            China Remdesivir Market Size, By Value (USD Million), 2020-2026F

    Figure 55:            China Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

    Figure 56:            China Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

    Figure 57:            China Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

    Figure 58:            China Remdesivir Market Share, By Application, By Value, 2020-2026F

    Figure 59:            China Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

    Figure 60:            South Korea Remdesivir Market Size, B